59 research outputs found

    Smells with cultural value: How to recognise and protect this heritage at risk?

    Get PDF
    Our engagement with heritage is largely visual whereas the potential of other sensory approaches is largely unexplored. Olfactory heritage is an emerging, interdisciplinary field linking material, intangible, and digital expressions of heritag

    A Multilingual Benchmark to Capture Olfactory Situations over Time

    Get PDF
    We present a benchmark in six European languages containing manually annotated information about olfactory situations and events following a FrameNet-like approach. The documents selection covers ten domains of interest to cultural historians in the olfactory domain and includes texts published between 1620 to 1920, allowing a diachronic analysis of smell descriptions. With this work, we aim to foster the development of olfactory information extraction approaches as well as the analysis of changes in smell descriptions over time

    Detection and localization of early- and late-stage cancers using platelet RNA

    Get PDF
    Cancer patients benefit from early tumor detection since treatment outcomes are more favorable for less advanced cancers. Platelets are involved in cancer progression and are considered a promising biosource for cancer detection, as they alter their RNA content upon local and systemic cues. We show that tumor-educated platelet (TEP) RNA-based blood tests enable the detection of 18 cancer types. With 99% specificity in asymptomatic controls, thromboSeq correctly detected the presence of cancer in two-thirds of 1,096 blood samples from stage I–IV cancer patients and in half of 352 stage I–III tumors. Symptomatic controls, including inflammatory and cardiovascular diseases, and benign tumors had increased false-positive test results with an average specificity of 78%. Moreover, thromboSeq determined the tumor site of origin in five different tumor types correctly in over 80% of the cancer patients. These results highlight the potential properties of TEP-derived RNA panels to supplement current approaches for blood-based cancer screening
    corecore